GlassScriptPhysician profile
Taras Kucher
NPI 1942210851
$38,368.17
in general payments reported to CMS, 2019-2025
33 companies · $12K in 2025
The $12K reported for 2025 was more than what 92% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,065 · 2020: $135 · 2021: $559 · 2022: $904 · 2023: $11K · 2024: $13K · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $32K · Food and Beverage: $3,310 · Travel and Lodging: $851.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $31,544.44 |
| Food and Beverage | $3,309.52 |
| Travel and Lodging | $851.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $31,732.71 | 2019-2025 | Auryon Laser System 100-120 Vac, Auryon Laser System 100-120 Vac |
| Medtronic, INC. | $1,802.59 | 2021-2025 | Ellipsys Vascular Access System, Endurant Iis, Abre |
| Inari Medical, INC. | $765.17 | 2019-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Janssen Pharmaceuticals, INC | $737.13 | 2019-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $518.45 | 2019-2025 | Eliquis |
| Abbott Laboratories | $336.54 | 2019-2025 | Esprit |
| Endologix LLC | $307.61 | 2023-2024 | Alto Abdominal Stent Graft System, Torus Stent Graft System, Endocross Device |
| Bard Peripheral Vascular, INC. | $260.00 | 2019-2023 | Crosser Iq |
| Pfizer INC. | $257.04 | 2019-2025 | |
| Medtronic Vascular, INC. | $175.85 | 2019-2020 | |
| Stryker Corporation | $171.84 | 2025 | Artix Mt, Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Silk Road Medical, INC. | $168.60 | 2019 | |
| Lemaitre Vascular, INC. | $157.72 | 2019-2025 | Artegraft Vascular Graft, Restoreflow |
| Philips North America LLC | $122.49 | 2021-2022 | |
| Tactile Systems Technology INC | $119.52 | 2023-2024 | Entre Plus, Flexitouch Plus |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $98.86 | 2020-2023 | Opticross 35 |
| Penumbra, INC. | $73.48 | 2022-2025 | Penumbra System |
| Asahi Intecc USA, INC. | $70.75 | 2025 | Asahi Peripheral Vascular Wires |
| Cook Medical LLC | $70.66 | 2019-2021 | |
| Veryan Medical Incorporated | $59.22 | 2021 | |
| Kerecis Limited | $51.27 | 2023-2025 | Kerecis Surgiclose, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Z-Medica, LLC | $44.32 | 2019 | |
| Merit Medical Systems INC | $43.04 | 2025 | Surfacer Inside-Out Catheter, Wrapsody Stent Graft |
| Solventum Corporation | $40.27 | 2024 | Activ.A.C., Prevena, V.A.C. Dermatac |
| Biocompatibles, INC. | $29.66 | 2019 | |
| Covidien LP | $25.92 | 2019 | |
| Cardiovascular Systems INC. | $24.15 | 2021 | |
| Kci USA, INC. | $20.72 | 2023 | Kerramax Care, Activ.A.C., Promogran Prisma |
| Shockwave Medical, INC | $20.67 | 2022 | |
| Sanara Medtech INC. | $17.90 | 2025 | Celleraterx |
| Paratek Pharmaceuticals, INC. | $15.76 | 2024 | Nuzyra |
| Cordis US Corp. | $15.36 | 2024 | Radial 360 |
| Ethicon US, LLC | $12.90 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Taras Kucher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.